RxDoctor Payments Data

Jarrod Kaufman, MD

Surgery · Brick, NJNPI 1154364073

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $353,863 of the $473,594 with a category attached, or 74.7%. 52 manufacturers reported payments, led by Musculoskeletal Transplant Foundation Inc. at 47.1% of the total. Reporting peaked in 2022 at $176,430 and has fallen 99.2% since, to $1,337 in 2025. Among surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$473,594in general payments, 2019–2025

Across 539 payments — averaging $878.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Musculoskeletal Transplant Foundation Inc.$223K
  • Innocoll Pharmaceuticals Limited$60K
  • Reddress USA, Inc.$54K
  • Kerecis Limited$37K
  • RTI Surgical, Inc$25K
  • Geistlich Pharma, North America, Inc.$14K
  • plus $60K from 46 others
$50,290in research payments, 2019–2025

Across 3 payments — averaging $16,763 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Davol Inc.$33K
  • BD$11K
  • Heron Therapeutics, Inc.$7K

What the payments were for

  • Royalty or licence$7660%
  • Consulting fees$353,86375%
  • Speaking & faculty fees$38,9508%
  • Travel & lodging$59,99313%
  • Food & beverage$20,0054%
  • Gifts$160%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$473,594 in reported general payments places this provider in the 95th percentile of 593 surgery providers in New Jersey.

See all surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$897,358
Medicare patients
222
Services billed
1,263

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sucralfate14$366
Mupirocin61$335
Ammonium Lactate14$182
Doxycycline Hyclate11$115
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen42$71

Paid to pharmacies, not to this prescriber.

Other surgery in Brick

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →